Evidence map›Paper›PMID 36263360›Full record

ArticleFrontiers in bioengineering and biotechnology2022

Multifunctional lignin-poly (lactic acid) biocomposites for packaging applications.

Esakkiammal Sudha Esakkimuthu, David DeVallance, Ievgen Pylypchuk, Adrian Moreno, Mika H Sipponen

Abstract read
In one paragraph

Article in Frontiers in bioengineering and biotechnology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Structure and Properties of Polylactide Composites with TiOInternational journal of molecular sciences · 2024
    Article
  7. Article
  8. Modified Biomass-Reinforced Polylactic Acid Composites.Materials (Basel, Switzerland) · 2024
    Review
  9. Article
  10. Review
  11. Review
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Esakkiammal Sudha EsakkimuthuInnoRenew CoE, Izola, Slovenia.
David DeVallanceInnoRenew CoE, Izola, Slovenia.
Ievgen PylypchukDepartment of Materials and Environmental Chemistry, Stockholm University, Stockholm, Sweden.
Adrian MorenoDepartment of Materials and Environmental Chemistry, Stockholm University, Stockholm, Sweden.
Mika H SipponenDepartment of Materials and Environmental Chemistry, Stockholm University, Stockholm, Sweden.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Lignin is the most abundant aromatic biopolymer with many promising features but also shortcomings as a filler in polymer blends. The main objective of this work was to improve the processability and compatibility of lignin with poly (lactic acid) (PLA) through etherification of lignin. Commercial kraft lignin (KL) and oxypropylated kraft lignin (OPKL) were blended with PLA at different weight percentages (1, 5, 10, 20, and 40%) followed by injection molding. Low lignin contents between 1 and 10% generally had a favorable impact on mechanical strength and moduli as well as functional properties of the PLA-based composites. Unmodified lignin with free phenolic hydroxyl groups rendered the composites with antioxidant activity, as measured by radical scavenging and lipid peroxidation tests. Incorporating 5-10% of KL or OPKL improved the thermal stability of the composites within the 300-350°C region. DSC analysis showed that the glass transition temperature values were systematically decreased upon addition of KL and OPKL into PLA polymer. However, low lignin contents of 1 and 5% decreased the cold crystallization temperature of PLA. The composites of KL and OPKL with PLA exhibited good stabilities in the migration test, with values of 17 mg kg

Indexed as

compositesligninmatrixmodificationpackagingpolylactic acidpolymer

Identifiers

PMID36263360
PMCPMC9574040

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.